Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma

Surgery (United States)

Volumn 154, Issue 6, 2013, Pages 1337-1345

  Kruijff, Schelto ^a   Aniss, Ahmed M ^a   Chen, Paul ^a   Sidhu, Stan B ^a   Delbridge, Leigh W ^a   Robinson, Bruce ^a   Clifton Bligh, Roderick J ^b   Roach, Paul ^b   Gill, Anthony J ^b   Learoyd, Diane ^b   Sywak, Mark S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN;

ABLATION THERAPY; ADULT; ARTICLE; CANCER MORTALITY; CANCER SIZE; CANCER STAGING; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DETERIORATION; DISTANT METASTASIS; DRUG MEGADOSE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; LOW DRUG DOSE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE RISK; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADULT; CARCINOMA; CARCINOMA, PAPILLARY; COHORT STUDIES; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84887999962     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.06.034     Document Type: Article

References (25)

1. J.A. Sipos, and E.L. Mazzaferri Thyroid cancer epidemiology and prognosis variables Clin Oncol 22 2010 395 404
2. Cancer Research UK. Thyroid cancer statistics - UK. Available from: http://info.cancer researchuk.org/cancerstats/types/thyroid.
3. National Cancer Institute. Thyroid cancer. Available from: http://www.cancer.gov/cancertopics/Types/thyroid.
4. A.M. Sawka, J.D. Brierley, R.W. Tsang, L. Thabane, L. Rotstein, and A. Gafni An updated systemic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer Endocrinol Metab Clin North Am 37 2008 457 480
5. B.H. Lang, I.O. Wong, K.P. Wong, B.J. Cowling, and K.Y. Wan Risk of second primary malignancy in differentiated thyroid carcinoma treated with radio active iodine therapy Surgery 151 2012 844 850
6. A.M. Sawka, L. Thabane, L. Parlea, I. Ibrahim-Zada, R.W. Tsang, and J.D. Brierley Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis Thyroid 19 2009 451 457
7. S.I. Sherman, P. Angelos, D.W. Ball, D. Byrd, O.H. Clark, and G.H. Daniels National Comprehensive Cancer Network Thyroid Carcinoma Panel 2007 NCCN clinical practical guidelines in oncology; thyroid carcinoma J Natl Compr Canc Netw 5 2007 568 621
8. D.S. Cooper, J.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, and S.J. Mandel Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
9. C. Schvartz, F. Bonnetain, S. Dabakuyo, M. Gauthier, A. Cueff, and S. Fieffé Survival after RAI therapy of DTC J Clin Endocrinol Metab 97 2012 1526 1535
10. T. Ibrahimpasic, I.J. Nixon, F.L. Palmer, M.M. Whitcher, R.M. Tuttle, and A. Shaha Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate risk papillary thyroid cancer- is there a need for radioactive iodine therapy? Surgery 6 2012 1096 1105
11. H.J. Kim, N.K. Kim, J.H. Choi, S.W. Kim, S.M. Jin, and S. Suh Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma Clin Endocrinol (Oxf) 75 2013 614 620
12. U. Mallick, C. Harmer, B. Yap, J. Wadsley, S. Clarke, and L. Moss Ablation with Low-dose radioiodine and thyrotroponine alfa in thyroid cancer N Engl J Med 18 2012 1674 1685
13. M. Schlumberger, B. Catargi, I. Borget, D. Deandreis, S. Zerdoud, and B. Boumediene Strategies of radioiodine ablation in patients with low risk thyroid cancer N Engl J Med 18 2012 1663 1673
14. R.A. DeLellis, R.V. Lloyd, P.U. Heitz, and C. Eng World Health Organization classification of tumours: Pathology and genetics - tumours of endocrine organs 2004 IARC Press Lyon
15. I.B. Hales, A. McElduff, P. Crummer, P. Clifton-Bligh, L. Delbridge, and R. Hoschl Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer J Clin Endocrinol Metab 75 1992 886 889
16. S.I. Sherman Thyroid carcinoma Lancet 361 2003 501 511
17. E.M. Chapman History of the discovery and early use of radioactive iodine JAMA 250 1983 2042 2044
18. S. Hertz, and A. Roberts Radioactive iodine in the study of thyroid physiology: VII. The use of radioactive iodine therapy in hyperthyroidism JAMA 131 1946 81 86
19. E.L. Saenger, G.E. Thoma, and E.A. Thompkins Cooperative study: incidence of leukemia following treatment of hyperthyroidism JAMA 205 1968 855 862
20. E.L. Mazzaferri, and R.T. Kloss Current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 96 2001 1447 1463
21. H. Creutzig High or low dose radioiodine ablation of thyroid remnants? Eur J Nucl Med 12 1987 500 502
22. S.A. Rivkees, C. Sklar, and M. Freemark The management of Graves' disease in children, with special emphasis on radioiodine treatment J Clin Endocrinol Metab 83 1988 3767 3776
23. C.S. Bal, A. Kumar, and G.S. Pant Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized controlled trial in 509 patients J Clin Endocrinol Metab 89 2004 1666 1673
24. A. Hackshaw, C. Harmer, U. Mallick, H. Masud, and J. Franklyn Review: I131 activity for remnant ablation in patients with differentiated thyroid cancer: a systemic review J Clin Endocrinol Metab 92 2007 28 38
25. H.O. Mäenpää, J. Heikkonen, L. Vaalavirta, M. Tenhunen, and H. Joensuu Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study PLoS One 3 2008 e1885